Jump to content

Talk:GNLY

Page contents not supported in other languages.
From Wikipedia, the free encyclopedia

This article was the subject of a Wiki Education Foundation-supported course assignment, between 5 January 2022 and 11 March 2022. Further details are available on the course page. Student editor(s): Immcarle181 (article contribs).

Bibliography Immcarle153

[edit]

[1] [2] [3] [4] Immcarle153 (talk) 23:36, 29 January 2021 (UTC)[reply]

References

  1. ^ Dotiwala, Farokh; Lieberman, Judy (October 2019). "Granulysin: killer lymphocyte safeguard against microbes". Current Opinion in Immunology. 60: 19–29. doi:10.1016/j.coi.2019.04.013.
  2. ^ Harris, Victoria; Jackson, Christopher; Cooper, Alan (18 December 2016). "Review of Toxic Epidermal Necrolysis". International Journal of Molecular Sciences. 17 (12): 2135. doi:10.3390/ijms17122135.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  3. ^ Liu, Xing; Lieberman, Judy (26 April 2020). "Knocking 'em Dead: Pore-Forming Proteins in Immune Defense". Annual Review of Immunology. 38 (1): 455–485. doi:10.1146/annurev-immunol-111319-023800.
  4. ^ Sparrow, E.; Bodman-Smith, M. D. (1 January 2020). "Granulysin: The attractive side of a natural born killer". Immunology Letters. 217: 126–132. doi:10.1016/j.imlet.2019.11.005.